Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited)

v3.25.2
Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue $ 0 $ 0 $ 0 $ 0
Expenses:        
Research and development 3,298 4,413 5,662 10,858
General and administrative 3,623 2,932 6,720 6,247
Operating expenses 6,921 7,345 12,382 17,105
Other income/(expense):        
Interest (expense) income (110) 93 (194) 214
Foreign exchange loss (12) (0) (10) (1)
Total other (loss) income (122) 93 (204) 213
Net loss (7,043) (7,252) (12,586) (16,892)
Other comprehensive loss:        
Unrealized loss on available-for-sale securities 0 1 0 0
Total comprehensive loss $ (7,043) $ (7,251) $ (12,586) $ (16,892)
Basic loss per common share $ (2.76) $ (12.99) $ (5.38) $ (33.91)
Diluted loss per common share $ (2.76) $ (12.99) $ (5.38) $ (33.91)
Weighted average number of common shares outstanding used in the calculation of basic loss per share (in shares) 2,552,429 558,476 2,340,535 498,113
Weighted average number of common shares outstanding used in the calculation of diluted loss per share (in shares) 2,552,429 558,476 2,340,535 498,113